- Report
- March 2024
- 664 Pages
Global
From €4749EUR$4,950USD£4,107GBP
- Report
- February 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- March 2020
- 150 Pages
Global
From €3056EUR$3,185USD£2,643GBP
€4366EUR$4,550USD£3,775GBP
- Report
- September 2023
- 84 Pages
Global
From €3500EUR$3,908USD£3,132GBP
- Report
- February 2022
- 155 Pages
Global
From €3562EUR$3,712USD£3,080GBP
The Resorbable Implant market is a subset of the larger Biomaterials market. It is composed of medical devices that are designed to be absorbed by the body over time. These implants are typically made of biodegradable polymers, such as polylactic acid, and are used in a variety of medical applications, including orthopedic, cardiovascular, and dental. Resorbable implants offer a number of advantages over traditional implants, such as reduced risk of infection and improved patient comfort.
Resorbable implants are becoming increasingly popular due to their ability to reduce the need for multiple surgeries and their potential to reduce the risk of long-term complications. As the technology continues to improve, the market is expected to grow.
Some of the major companies in the Resorbable Implant market include Stryker, Zimmer Biomet, DePuy Synthes, and Smith & Nephew. Show Less Read more